Article info
PDFLiver
Randomised, double blind, placebo controlled trial of interferon, ribavirin, and amantadine versus interferon, ribavirin, and placebo in treatment naïve patients with chronic hepatitis C
- Correspondence to:
Dr P J Thuluvath
Division of Gastroenterology and Hepatology, the Johns Hopkins University School of Medicine, 1830 E Monument Street, Suite 429, Baltimore, MD 21205, USA; pjthuluvjhmi.edu
Citation
Randomised, double blind, placebo controlled trial of interferon, ribavirin, and amantadine versus interferon, ribavirin, and placebo in treatment naïve patients with chronic hepatitis C
Publication history
- Accepted August 19, 2003
- First published December 18, 2003.
Online issue publication
April 18, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 by Gut